Playlist

Population Resettlement to Continue in Arkadag City Under National Leader's Guidance

03 May. 03:59

Source

The National Leader of the Turkmen people and Chairman of the Halk Maslahat conducted a working visit to Arkadag City to oversee its ongoing development and population resettlement efforts. During a high-level meeting with urban development officials, it was reported that the first phase of construction provided housing for 7,368 families. The focus has now shifted toward the second phase, which includes the construction of residential units for an additional 4,284 families alongside essential social infrastructure.

The second stage of the city's expansion is designed as a comprehensive urban ecosystem. Plans emphasize the simultaneous construction of modern residential buildings, secondary schools, and kindergartens to support a growing population. Every architectural project adheres to high-tech and "smart city" standards, ensuring that residents have access to premium living conditions and recreational facilities that meet modern global requirements.

The National Leader emphasized that the resettlement of citizens into these fully-equipped residential complexes must proceed systematically. Since its inauguration, Arkadag City has quickly become a vibrant hub, creating thousands of new jobs and integrating digital solutions into daily life. The goal is to ensure that the urban environment remains fully responsive to the needs and preferences of its inhabitants, maintaining the high quality of life established in the initial phase.

Education and youth empowerment remain at the forefront of the city's strategic development. To encourage academic excellence, the National Leader proposed the introduction of specialized scholarships for students attending educational institutions within Arkadag City. Furthermore, relevant officials were instructed to modernize the management of local schools and universities, ensuring that the next generation is educated in an innovative environment that fosters both talent and patriotism.

‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌

Simple Vitamin Shows Surprising Results in Pre-Cancerous Blood Conditions, Study Finds

Today in 02:02

Source

Daily high-dose supplementation of vitamin C can significantly reduce mortality risks and help prevent severe medical complications in patients with pre-cancerous blood conditions. Researchers from the Van Andel Institute in the United States and Copenhagen University Hospital in Denmark reached this conclusion following a comprehensive three-year follow-up study. The international "EVITA" trial involved volunteers who were administered 1,000 mg of vitamin C daily over the course of a year, while a control group received a placebo.

Although initial hypotheses suggested vitamin C might directly inhibit abnormal cell proliferation, researchers found its primary benefit lay in strengthening the body, reducing systemic inflammation, and lowering rates of anemia, pneumonia, and internal bleeding. Over the three-year observation period, the vitamin C group exhibited a significantly higher survival rate compared to the placebo group. While experts emphasize that these findings remain preliminary and require larger clinical trials before reshaping formal medical treatment protocols, vitamin C continues to show promising potential in supportive patient care.

‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌